Efficacy and safety of a Venus A valve among Chinese patients undergoing transcatheter aortic valve replacement: a systematic review and single-arm meta-analysis
Despite its relatively high requirement for a second valve, the Venus A valve is feasible for Chinese patients undergoing TAVR. Its effectiveness and safety were demonstrated by a high device/procedure success rate, immediate hemodynamic improvement, and low incidence of complications.
Authors
- Changli Liu (ORCID: https://orcid.org/0000-0002-4531-5749)
- Dongkai Shan
- T. Chen
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Yingqian Zhang
- Jun Guo
- Tianwen Han
- Bo Jiang
- Zeyu Sun
- Weiran Wang
Institutions
- Chinese PLA General Hospital (CN)
- First Affiliated Hospital of Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fcvm.2026.1725106
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- General Hospital of People’s Liberation Army
- National Science and Technology Major Project
- National Key Research and Development Program of China